SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Pump's daily trading recs, emphasis on short selling

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Michail Shadkin who started this subject6/6/2001 10:13:58 AM
From: Michail Shadkin  Read Replies (1) of 6873
 
HBIO - reasons for going long

Harvard Bioscience, Inc. is a provider of research enabling tools for drug discovery. The Company provides an array of tools designed to accelerate the speed and to reduce the cost at which its customers can introduce new drugs. Since its 1996 reorganization, the Company has focused on alleviating the protein purification and absorption, distribution, metabolism, elimination and toxicology (ADMET) screening bottlenecks in drug discovery.

cap is 207 million
cash is 1.65/share
zero debt

last 4 quarters eps is
+.02, +.03, +.05, latest is +.05

expect +.04 next quarter
2001 expect +.19
2002 expect +.29

forward pe is 27 (not too expensive)

Very large lockup was on monday, giant volume yesterday.
significant fall over last week.
thestreet.com

pressure should ease over next few day and HBIO should get to over 10 within a few weeks

very nice support at 8.00 and around 7.40

this should be very similar to my TMTA call right after their lockup.

Please dont chase the price.

traderpulse.com
Michail
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext